Shire Rejects AbbVie's Offer, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 4:31PM CDT
Shares of Shire plc (SHPG) soared 16.3% after the company rejected an acquisition offer from AbbVie (ABBV).
Cost Controls vs. Curing Citizens: Fallout from the U.K.
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon Jun 23, 4:30PM CDT
Just like the protagonist in " Fortunately, Unfortunately " Gilead Sciences is experiencing a disproportionate amount of highs and lows. Fortunately, the big biotech released great phase 3 data out of Japan for an experimental hepatitis-c combo...
Is Shire's Dividend Safe?
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 23, 4:30PM CDT
Shire ( ) is one of the globe's biggest drug companies. It's a major player in ADHD and rare disease, and the company has been rumored as a takeover target by Allergan , and recently AbbVie announced its third attempt to buy the...
Shots Fired in the Next Tax Fleeing Battle
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon Jun 23, 4:15PM CDT
Perpetual takeover target Shire is officially in play. Long rumored as a takeover candidate given its strong ADHD franchise, its orphan drug focus, and most importantly its low Irish tax rates, Shire has an actual suitor in big pharma AbbVie ....
Takeover target Shire promises strong growth
AP - Mon Jun 23, 10:44AM CDT
LONDON (AP) — Takeover target Shire on Monday highlighted its potential as a standalone drugmaker, offering investors a rosy projection of its earnings potential that it believes is not reflected in the acquisition proposal made by U.S.-based rival AbbVie.
AbbVie, Shire Give Bullish Guidance Amid Buyout Talk
at Investor's Business Daily - Mon Jun 23, 10:24AM CDT
Big pharma AbbVie (ABBV) raised its 2014 earnings guidance Monday, sending the company's stock up 1.5% in morning trading on the stock market. Meanwhile, AbbVie's buyout target Shire (SHPG) detailed its own bullish guidance in explaining to investors...
Stocks Lower In Early Trade; Buffalo Wild Wings Breaks Out
at Investor's Business Daily - Mon Jun 23, 9:34AM CDT
Stocks were narrowly lower early Monday, with gains from some better-than-expected economic data doing little to boost the market. The Nasdaq and the S&P 500 were down 0.1%. The Dow Jones industrial average was off 0.2%. Volume was tracking lower on...
Stock Market News for June 23, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 9:06AM CDT
Benchmarks closed Friday’s trading session with modest gains as optimism from Wednesday’s policy statement spilled over into a second successive day
Monday’s Top Biotech Stocks to Watch: Rockwell, AbbVie, Shire, Allergan, and Valeant
Leo Sun, The Motley Fool - Motley Fool - Mon Jun 23, 8:20AM CDT
Let's take a look at five stocks -- Rockwell Medical , AbbVie , Shire , Allergan , and Valeant Pharmaceuticals -- which could all loom large in health care headlines this Monday morning. FDA approves Rockwell Medical's Calcitriol ...
Why AbbVie (ABBV) Stock Is Higher This Morning
at The Street - Mon Jun 23, 7:46AM CDT
Shares of AbbVie (ABBV) are up in pre-market trade as the pharmaceuticals company raised the midpoint of its full-year 2014 earnings-per-share guidance.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
PR Newswire Europe - Mon Jun 23, 7:11AM CDT
- AbbVie Raises Outlook for 2014
Here's Why AbbVie Wants to Cozy Up With Shire
Todd Campbell, The Motley Fool - Motley Fool - Sun Jun 22, 8:40PM CDT
Shire's c-suite thinks the company's future is pretty bright. The company's board dismissed a $46 billion offer to be acquired by drug giant AbbVie in May, even though that offer represented a 23% premium to its pre-offer price. According to...
This Week in Biotech: A Double-Dose of Hot Potato
Sean Williams, The Motley Fool - Motley Fool - Sat Jun 21, 11:32AM CDT
With the SPDR S&P Biotech Index up 52% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
Growth Stocks Kick Into Gear In Latest IBD 50 Screen
at Investor's Business Daily - Fri Jun 20, 5:35PM CDT
Have you noticed? Growth stocks are back in favor as major stock indexes sit near highs. The IBD 50 has come back to life in recent weeks. Since its mid-April low, the index is up 12% compared with an 8% gain for the S&P 500. Solid price action by...
Why AbbVie Wants Shire
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Fri Jun 20, 5:00PM CDT
Shares in Irish orphan and ADHD drug maker Shire Plc shot up today on the news that AbbVie , faced with the oncoming patent loss for Humira and looking to lower its tax rate, made public a rejected $46.5 billion bid today. This was the third bid...
Business Highlights
By The Associated Press - AP - Fri Jun 20, 4:47PM CDT
___
Why CarMax, Shire, and BlackBerry Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Fri Jun 20, 4:15PM CDT
The week ends as it began -- on a positive note, with the broad-based S&P 500 rising for a sixth-straight session and claiming another all-time high close. With no economic data on the table today, investors used ongoing merger and...
ConocoPhillips and Owens are big market movers
AP - Fri Jun 20, 3:30PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Just a Regular Day of Record Highs, No Big Deal
at The Street - Fri Jun 20, 3:21PM CDT
The S&P 500 is making this look easy as it closes at another record high to end the week. Since Monday, the benchmark index is up 1.38%.